Epizyme proposes follow-on

Epizyme Inc. (NASDAQ:EPZM), Cambridge, Mass. Business: Cancer Date announced: 1/27/14 Type: Follow-on To be raised: Up to $140 million Shares: TBD Price prior: $34.94 Underwriters: Citigroup; Cowen; L...